Press release
Related Press

22 February 2024
CSEM and ClexBio create a bioreactor for tissue-engineered cardiovascular implants
The teams at CSEM and at ClexBio have developed a process for engineering vein grafts comprised of human tissue material that integrates into the patient’s body and can turn into real, living tissue....

3 September 2025
Breakthrough in mitochondria therapy: CSEM and cellvie automate isolation process for clinical use
cellvie and CSEM are advancing an automated solution to standardize mitochondrial therapy manufacturing, accelerating treatment for ischemia-reperfusion injury and potentially helping over 3 million p...

23 January 2025
CSEM and TheraMe! revolutionize cancer therapy with personalized drug screening technology
What if there was a solution allowing to test which drug or drug combination works best on the tumor cells of a given patient at any given stage of the disease?...
